Skip to content

Clinical trials

Phase 3 Squamous Cell Carcinoma of Head and Neck trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 3 Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20092
20141
20151
20161
20173
20204
20211
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bristol-Myers Squibb2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Merus B.V.2
AVEO Pharmaceuticals, Inc.1
Corbus Pharmaceuticals Inc.1
EMD Serono Research & Development Institute, Inc.1
Incyte Corporation1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck20
Head and Neck Neoplasms7
Carcinoma, Squamous Cell2
Laryngeal Diseases2
Anemia1
Neoplasm Metastasis1
Oropharyngeal Neoplasms1
Recurrence1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.